Upcoming IPOs
Companies that have filed to go public with the SEC, from their S-1 and F-1 registration statements. The largest offerings get a full breakdown of the filing.
UpdatedIPO analysis
Recent filings
Offerings led by a large investment bank, the IPOs most investors follow. Switch to all filings to include smaller deals. Companies without a link don't have an analysis yet.
| Company | Ticker | Status | Filed | Industry | Lead banks | Filing |
|---|---|---|---|---|---|---|
| Bambusa Therapeutics, Inc. | BBTX | Amended | Oct 9, 2026 | Biological Products, (No Diagnostic Substances) | BofA Securities, Evercore | S-1/A |
| Aspen Neuroscience, Inc. | ASPE | Amended (2) | Oct 9, 2026 | Pharmaceutical Preparations | UBS | S-1/A |
| Anthropic, PBC | ANT | Filed | Oct 26, 2026 | Services-Prepackaged Software | Goldman Sachs, Morgan Stanley | Analysis |
| Lycia Therapeutics, Inc. | LYCA | Trading | Oct 5, 2026 | Biological Products, (No Diagnostic Substances) | Jefferies, Evercore | S-1/A |
| OPAY Ltd | OPAY | Amended | Oct 9, 2026 | Functions Related To Depository Banking, NEC | Citigroup, Deutsche Bank | F-1/A |
| WINDWARD BIO GROUP AG | WWB | Filed | Oct 23, 2026 | Biological Products, (No Diagnostic Substances) | Jefferies, UBS | F-1 |
| NODTHERA INC. | RZRA | Filed | Oct 21, 2026 | Pharmaceutical Preparations | Jefferies | S-1 |
| CITY THERAPEUTICS, INC. | CTY | Trading | Sep 24, 2026 | Pharmaceutical Preparations | Goldman Sachs, Jefferies | S-1/A |
| Iambic Therapeutics, Inc. | IAM | Trading | Sep 21, 2026 | Biological Products, (No Diagnostic Substances) | J.P. Morgan, BofA Securities | S-1/A |
| vVARDIS Holding AG | VVVV | Filed | Oct 9, 2026 | Surgical & Medical Instruments & Apparatus | Goldman Sachs, J.P. Morgan | F-1 |
| TRex Bio, Inc. | TRXB | Trading | Sep 18, 2026 | Biological Products, (No Diagnostic Substances) | J.P. Morgan, Evercore | S-1/A |
| Patriot Mobile Inc. | PTRT | Filed | Oct 9, 2026 | Radiotelephone Communications | Wells Fargo | S-1 |
| Centinel Spine Holdco, Inc. | CNTL | Filed | Oct 7, 2026 | Surgical & Medical Instruments & Apparatus | Goldman Sachs, Morgan Stanley | S-1 |
| DayOne Data Centers Ltd | DODC | Filed | Oct 5, 2026 | Services-Computer Programming, Data Processing, Etc. | Morgan Stanley, J.P. Morgan | F-1 |
| Accelevation Holdings Corp. | ACCV | Trading | Sep 2, 2026 | Electrical Industrial Apparatus | Goldman Sachs, Morgan Stanley | S-1/A |
| ADARx Pharmaceuticals, Inc. | ADRX | Trading | Sep 4, 2026 | Pharmaceutical Preparations | Morgan Stanley, J.P. Morgan | S-1/A |
| Holtec Nuclear Corp | HNUC | Withdrawn | Jul 10, 2026 | Construction - Special Trade Contractors | Goldman Sachs, Morgan Stanley | S-1/A |
| TFP Group Ltd | TFP | Filed | Sep 25, 2026 | Insurance Agents, Brokers & Service | Morgan Stanley, J.P. Morgan | F-1 |
| Wella Co | WELA | Amended | Aug 31, 2026 | Perfumes, Cosmetics & Other Toilet Preparations | Goldman Sachs, J.P. Morgan | S-1/A |
| Orion180 Insurance Group Inc. | OIG | Trading | Aug 20, 2026 | Insurance Agents, Brokers & Service | Goldman Sachs, UBS | S-1/A |
| Oura Inc. | OURA | Amended | Sep 3, 2026 | Electronic Computers | Goldman Sachs, Morgan Stanley | S-1/A |
| SB Energy, Inc. | SBE | Amended (2) | Sep 1, 2026 | Electric Services | Goldman Sachs, Morgan Stanley | S-1/A |
| Electra Therapeutics, Inc. | ETRA | Trading | Aug 28, 2026 | Biological Products, (No Diagnostic Substances) | Jefferies, Evercore | S-1/A |
| NSCALE Ltd | NSCL | Filed | Sep 18, 2026 | Services-Prepackaged Software | Goldman Sachs, Morgan Stanley | S-1 |
| Aggreko Inc. | AGKO | Amended | Aug 24, 2026 | Cogeneration Services & Small Power Producers | Goldman Sachs, Morgan Stanley | F-1/A |
| Bamboo Insurance Services, Inc. | BMB | Amended | Aug 28, 2026 | Insurance Agents, Brokers & Service | Goldman Sachs, Morgan Stanley | S-1/A |
| Cumberland Farms Ltd | CMBY | Amended | Jul 2, 2026 | Retail-Auto Dealers & Gasoline Stations | Goldman Sachs, J.P. Morgan | F-1/A |
| ENTRATA, INC. | ENT | Amended (2) | May 28, 2026 | Services-Prepackaged Software | Goldman Sachs, J.P. Morgan | S-1/A |
| Syntiant Corp. | SYTN | Amended (2) | Jul 6, 2026 | Semiconductors & Related Devices | BofA Securities, Citigroup | S-1/A |
| Tailored Brands, Inc. / DE | MW | Amended | Jul 10, 2026 | Retail-Apparel & Accessory Stores | Goldman Sachs, Morgan Stanley | S-1/A |
| CoVolt Power, Inc. | KVLT | Filed | Aug 21, 2026 | Electric & Other Services Combined | J.P. Morgan, Jefferies | S-1 |
| Lyntris Inc. | LYNX | Trading | Jul 23, 2026 | Search, Detection, Navigation, Guidance, Aeronautical Sys | Citigroup, Evercore | S-1/A |
| BlossomHill Therapeutics, Inc. | BLSM | Trading | Jul 17, 2026 | Pharmaceutical Preparations | J.P. Morgan | S-1/A |
| Latigo Biotherapeutics, Inc. | LTGO | Trading | Jul 17, 2026 | Pharmaceutical Preparations | Goldman Sachs, Jefferies | S-1/A |
| Braveheart Bio, Inc. | BRVE | Trading | Jul 15, 2026 | Pharmaceutical Preparations | Goldman Sachs, Jefferies | S-1/A |
| Attovia Therapeutics, Inc. | ATTO | Trading | Jul 14, 2026 | Biological Products, (No Diagnostic Substances) | Morgan Stanley, Citigroup | S-1/A |
| Apnimed, Inc. | APMD | Trading | Jul 10, 2026 | Pharmaceutical Preparations | BofA Securities, Evercore | S-1/A |
| Jersey Mike's Subs Inc. | JMKE | Trading | Jul 2, 2026 | Retail-Eating Places | Goldman Sachs, Morgan Stanley | S-1/A |
| Ionic Digital Inc. | IOND | Trading | Jun 29, 2026 | Finance Services | J.P. Morgan, Jefferies | S-1/A |
| Scribe Therapeutics, Inc. | SCTX | Trading | Jul 2, 2026 | Biological Products, (No Diagnostic Substances) | Goldman Sachs, Wells Fargo | S-1/A |
| Genneia S.A. | GENN | Amended | Jul 2, 2026 | Electric Services | Morgan Stanley, J.P. Morgan | F-1/A |
| Standard Nuclear, Inc. | STDN | Trading | Jun 18, 2026 | Industrial Inorganic Chemicals | Goldman Sachs, BofA Securities | S-1/A |
| Csquare, Inc. | CSQR | Trading | Jun 16, 2026 | Services-Computer Programming, Data Processing, Etc. | Morgan Stanley, J.P. Morgan | S-1/A |
| SK hynix Inc. | SKHY | Trading | Jun 24, 2026 | Semiconductors & Related Devices | Goldman Sachs, J.P. Morgan | F-1/A |
Source: SEC EDGAR. Status comes from each company's filings: an amended S-1, a final prospectus (priced), a withdrawal request, or a listed ticker (trading).